Fatty acid metabolic imaging with 123i-bmipp for the diagnosis of coronary artery disease application to patients with diabetes mellitus and hyperlipidaemia

Nuclear Medicine Communications

Volumn 17, Issue 8, 1996, Pages 675-680

  Takeishi, Yasuchika ^a   Atsumi, H ^a   Fujiwara, S ^a   Takahashi, K ^a   Tomoike, H ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEART MUSCLE METABOLISM; HEART SCINTISCANNING; HUMAN; HYPERLIPIDEMIA; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE;

EID: 0029738378     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199608000-00005     Document Type: Article

References (16)

1. Knapp F, Goodman M, Ambrose K, et al. The development of radioiodinated 3-methyl-branched fatty acids for evaluation of myocardial disease by single photon techniques. In Van der Wall EE, ed. Noninvasive imaging of cardiac metabolism. Dordrecht: Martinus Nijhoff Publishers, 1987: 159-201.
2. Knapp FF, Kropp J, Goodman M, et al. The development of iodine-123-methyl-branched fatty acids and their applications in nuclear cardiology Ann Nucl Med 1993; 7: SII 1-14.
3. Takeishi Y, Chiba J, Abe S, Tonooka I, Komatani A, Tomoike H. Heterogeneous myocardial distribution of iodine-123 15-p-iodophenyD-3-R, S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy. Eur J Nucl Med 1992; 19: 775-782.
4. Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: Assessment with emission tomography using an iodinated branched fatty acid analogue. J Nucl Med 1992; 33: 659-667.
5. 123I-beta-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med 1994; 21: 283-291.
6. Matsunari I, Saga T, Taki J et al. Kinetics of iodine- 123-BMIPP in patients with prior myocardial infarction: Assessment with dynamic rest and stress images compared with stress thallium-201 SPECT. J Nucl Med 1994; 35: 1279-1285.
7. Franken P, Geeter F, Dendale P, Demoor D, Block P, Bossuyt A. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: Correlation with wall motion and inotropic reserve. J Nucl Med 1994; 35: 1758-1765.
8. Knapp F, Franken P, Kropp J. Cardiac SPECT with iodine- 123-labeled fatty acids: Evaluation of myocardial viability with BMIPP. J Nucl Med 1995; 36: 1022-1030.
9. Knapp F, Kropp J. Iodine-123-labeled fatty acids for myocardial single-photon emission tomography: Current status and future perspectives. Eur J Nucl Med 1995; 22: 361-381.
10. 123I-BMIPP in patients with stable effort angina pectoris. Nucl Med Commun 1995; 16: 1002-1008.
11. m-sestamibi. Ann Nucl Med 1995; 9: 125-130.
12. Neely R, Rovetto J, Oram F. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 1972; 15: 289-299.
13. Shelbert H, Phelps M, Hoffman E, Huang S, Kuhl D. Regional myocardial blood flow, metabolism and function assessed noninvasively with positron emission tomography. Am J Cardiol 46: 1269-1277.
14. Yamamichi Y, Kusuoka H, Morishita K et al. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med 1995; 36: 1043-1050.
15. Ishii Y, MacIntyre WJ. Measurement of total myocardial blood flow in dogs with 43K and the scintillation camera. Circ Res 1973; 33: 113-122.
16. Vyska M, Machulla H, Stremmel W et al. Regional myocardial free fatty acid extraction in normal and ischemic myocardium. Circulation 1988; 78: 1218-1233.